持続グルコースモニタリング市場 - 成長、将来展望、競合分析、2025年～2033年

持続グルコースモニタリング（CGM）システムは、昼夜を問わずリアルタイムでグルコースレベルを追跡する高度な医療機器です。このシステムにより、糖尿病患者は自分のグルコースレベルをリアルタイムで確認したり、身体に取り付けたセンサーで数日間にわたって遠隔監視したりすることができます。CGMシステムは、グルコースレベルの動向やパターンを特定するために使用できるデータを提供し、食事、運動、インスリンの必要量を調整するのに役立ちます。この技術は、一度に単一のグルコース測定値しか提供しない従来の血糖測定器とは異なり、グルコース動態に関する包括的な洞察を提供するため、糖尿病管理に不可欠です。持続グルコースモニタリングの市場規模は、世界の糖尿病有病率の上昇とリアルタイムグルコースモニタリングソリューションに対する需要の高まりにより、年間平均成長率（CAGR）9.6％で拡大すると予測されています。

持続グルコースモニタリング（CGM）市場の重要な促進要因は、世界の糖尿病有病率の上昇です。糖尿病は世界の流行となっており、2021年には5億3,700万人の成人が糖尿病を患っていると推定され、2030年には6億4,300万人に増加すると予測されています。この急増は、特に都市部における肥満、食生活の乱れ、座りっぱなしのライフスタイルの増加によるところが大きいです。糖尿病人口の増加により、血糖値を監視・管理するための効果的な管理ツールが必要となり、CGMシステムの需要が高まっています。これらのデバイスは、グルコース動向に関するリアルタイムの洞察を提供し、患者が自分の状態をより効果的に管理できるようにし、タイムリーな介入を促進することで、低血糖や高血糖などの糖尿病関連合併症のリスクを低減します。

CGM市場の成長機会は、CGM機器とより広範なデジタルヘルスプラットフォームとの統合によって大幅に強化されます。デジタルヘルス技術の進歩に伴い、CGMシステムを含む複数のソースからのデータを統合し、患者の健康状態を包括的に把握できるプラットフォームの開発傾向が強まっています。この統合により、食事、運動、その他の健康データに基づいてグルコースの変動を予測できる人工知能や機械学習アルゴリズムに支えられ、よりパーソナライズされた正確な糖尿病管理戦略が可能になります。さらに、このデータをヘルスケアプロバイダーとシームレスに共有できることで、遠隔モニタリング機能が強化され、遠隔医療や遠隔健康管理を目指す世界の動きが進む中で、特に重要な遠隔地からの効果的な糖尿病管理が容易になります。

当レポートでは、世界の持続グルコースモニタリング市場について調査し、市場の概要とともに、デバイス/ブランド別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 持続グルコースモニタリング市場：競合分析

• 主要ベンダーの市場ポジショニング
• ベンダーが採用する戦略
• 主要業界戦略

第4章 持続グルコースモニタリング市場：マクロ分析と市場力学

• イントロダクション
• 世界の持続血糖モニタリングの市場価値、2023年～2033年
• 市場力学
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
• PESTEL分析

第5章 持続グルコースモニタリング市場：2023年～2033年

• 市場概要
• 成長と収益分析：2024年対2033年
• 市場セグメンテーション

第6章 持続グルコースモニタリング市場：デバイス/ブランド別、2023年～2033年

• 市場概要
• 成長と収益分析：2024年対2033年
• 市場セグメンテーション
  • ガーディアンリアルタイムCGMシステム
  • デクスコムセブンプラス
  • デクスコムG4プラチナ
  • フリースタイルナビゲーター
  • MiniMedパラダイムRevel/Veoシステム
  • その他

第7章 北米の持続グルコースモニタリング市場：2023年～2033年

第8章 英国およびEUの持続グルコースモニタリング市場：2023年～2033年

第9章 アジア太平洋の持続グルコースモニタリング市場：2023年～2033年

第10章 ラテンアメリカの持続グルコースモニタリング市場：2023年～2033年

第11章 中東・アフリカの持続グルコースモニタリング市場：2023年～2033年

第12章 企業プロファイル

• Abbott
• Bayer AG
• Dexcom Inc.
• Glysens Incorporated
• Insulet Corporation
• Medtronic
• Nova Biomedical Corporation
• Senseonics Incorporated
• Livongo
• BeatO
• Jana Care
• iXensor
• DiaMonTech AG.

List of Tables

• TABLE 1 Global Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 2 Global Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 3 North America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 4 North America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 5 U.S. Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 6 U.S. Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 7 Canada Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 8 Canada Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 9 Rest of North America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 10 Rest of North America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 11 UK and European Union Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 12 UK and European Union Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 13 UK Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 14 UK Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 15 Germany Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 16 Germany Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 17 Spain Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 18 Spain Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 19 Italy Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 20 Italy Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 21 France Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 22 France Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 23 Rest of Europe Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 24 Rest of Europe Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 25 Asia Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 26 Asia Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 27 China Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 28 China Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 29 Japan Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 30 Japan Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 31 India Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 32 India Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 33 Australia Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 34 Australia Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 35 South Korea Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 36 South Korea Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 37 Latin America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 38 Latin America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 39 Brazil Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 40 Brazil Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 41 Mexico Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 42 Mexico Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 43 Rest of Latin America Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 44 Rest of Latin America Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 45 Middle East and Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 46 Middle East and Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 47 GCC Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 48 GCC Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 49 Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 50 Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)
• TABLE 51 Rest of Middle East and Africa Continuous Glucose Monitoring Market By , 2023-2033, USD (Million)
• TABLE 52 Rest of Middle East and Africa Continuous Glucose Monitoring Market By Device/Brand, 2023-2033, USD (Million)

List of Figures

• FIG. 1 Global Continuous Glucose Monitoring Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Continuous Glucose Monitoring Market: Quality Assurance
• FIG. 5 Global Continuous Glucose Monitoring Market, By , 2024
• FIG. 6 Global Continuous Glucose Monitoring Market, By Device/Brand, 2024
• FIG. 7 Global Continuous Glucose Monitoring Market, By Geography, 2024
• FIG. 8 Market Geographical Opportunity Matrix - Global Continuous Glucose Monitoring Market, 2024
• FIG. 9Market Positioning of Key Continuous Glucose Monitoring Market Players, 2024
• FIG. 10 Global Continuous Glucose Monitoring Market, By , 2024 Vs 2033, %
• FIG. 11 Global Continuous Glucose Monitoring Market, By Device/Brand, 2024 Vs 2033, %

Continuous Glucose Monitoring (CGM) systems are advanced medical devices that track glucose levels in real-time throughout the day and night. These systems allow individuals with diabetes to see their glucose levels in real-time or monitor them remotely over several days via sensors that are attached to the body. CGM systems provide data that can be used to identify trends and patterns in glucose levels, which can help in tailoring diet, exercise, and insulin requirements. This technology is vital for diabetes management as it provides comprehensive insights into glucose dynamics, unlike traditional blood glucose meters, which only provide a single glucose reading at a time. The continuous glucose monitoring market is projected to expand at a Compound Annual Growth Rate (CAGR) of 9.6%, driven by the increasing prevalence of diabetes globally and the growing demand for real-time glucose monitoring solutions.

Increasing Prevalence of Diabetes

A significant driver for the continuous glucose monitoring (CGM) market is the escalating prevalence of diabetes worldwide. Diabetes has become a global epidemic, with an estimated 537 million adults living with the condition in 2021, a number expected to rise to 643 million by 2030. This surge is largely due to increasing rates of obesity, poor dietary habits, and sedentary lifestyles, especially in urban environments. The growing diabetic population necessitates effective management tools to monitor and control blood glucose levels, thus driving demand for CGM systems. These devices provide real-time insights into glucose trends, enabling patients to manage their condition more effectively and reduce the risk of diabetes-related complications, such as hypoglycemia and hyperglycemia, by facilitating timely interventions.

Integration with Digital Health Platforms

The opportunity for growth in the CGM market is significantly enhanced by the integration of CGM devices with broader digital health platforms. As digital health technology advances, there is a growing trend toward the development of platforms that can integrate data from multiple sources, including CGM systems, to provide a comprehensive overview of a patient's health. This integration allows for more personalized and precise diabetes management strategies, supported by artificial intelligence and machine learning algorithms that can predict glucose fluctuations based on diet, exercise, and other health data. Moreover, the ability to share this data seamlessly with healthcare providers enhances remote monitoring capabilities, making it easier to manage diabetes effectively from a distance, particularly important in the context of the ongoing global push towards telemedicine and remote health management.

Cost and Accessibility Barriers

Despite the benefits of CGM systems, a significant restraint is their cost, which remains prohibitively high for many potential users, especially in low- and middle-income countries. The expense of CGM devices, which includes not only the initial purchase price but also ongoing costs related to sensors, which need regular replacement, can be a barrier to widespread adoption. Additionally, there are accessibility issues, as these systems often require a certain level of technological literacy and access to supportive digital infrastructure, such as smartphones or reliable internet, which may not be available to all users. This economic and technological divide limits the potential market reach of CGM systems and poses challenges to their universal adoption among the global diabetic population.

Data Privacy and Security Concerns

A critical challenge in the CGM market is addressing concerns related to data privacy and security. As CGM systems collect and store vast amounts of personal health information, there is an inherent risk of data breaches, which could expose sensitive health data. The challenge is compounded as these devices become more interconnected with other health systems and platforms, increasing the number of potential vulnerability points. Ensuring robust data protection measures is paramount to maintaining user trust and compliance with stringent regulatory standards regarding health data. This requires continuous investment in cybersecurity measures and regular updates to security protocols, which can be resource-intensive but are essential for safeguarding patient information and ensuring the integrity of remote monitoring health services.

Market Segmentation by Device/Brand

In the continuous glucose monitoring (CGM) market, segmentation by device/brand includes Guardian Real Time CGM System, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, and others. Currently, the Dexcom G4 Platinum holds the highest revenue within this segment, attributed to its high accuracy, reliability, and user-friendly interface, which have made it popular among diabetes patients seeking rigorous glucose management. Dexcom's strong brand recognition and established distribution channels contribute significantly to its leading market position. However, the FreeStyle Navigator is projected to experience the highest CAGR. This anticipated growth is driven by its newer technology that offers real-time glucose monitoring without the need for fingerstick calibration, providing greater convenience and reducing the invasiveness of glucose monitoring. As technology advances and patient preferences evolve towards less invasive and more integrated diabetes management solutions, devices like the FreeStyle Navigator are expected to gain significant traction, reflecting broader trends in patient-centered healthcare innovations.

Geographic Trends in the Continuous Glucose Monitoring Market

The continuous glucose monitoring (CGM) market exhibits substantial geographic variations, with North America having generated the highest revenue in 2024. This region's market dominance is attributed to a high prevalence of diabetes, well-established healthcare infrastructure, and widespread adoption of advanced diabetes management technologies. Additionally, favorable reimbursement policies and strong presence of major market players have further supported the extensive use of CGM systems in this region. However, Asia-Pacific is expected to witness the highest CAGR from 2025 to 2033. This growth is driven by increasing awareness of diabetes management, rising healthcare expenditures, and improving healthcare infrastructures in populous countries like China and India. Moreover, the growing middle class in this region is increasingly able to afford advanced healthcare solutions, which contributes to the rapid adoption of innovative technologies such as CGM systems.

Competitive Trends and Key Strategies

In 2024, the competitive landscape of the CGM market was shaped by key players such as Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation, Senseonics Incorporated, Livongo, BeatO, Jana Care, iXensor, and DiaMonTech AG. These companies employed a range of strategies to enhance their market positions, including innovation in product offerings, strategic partnerships, and expansions into new geographic markets. For instance, companies like Dexcom and Medtronic focused on technological advancements to improve the accuracy and user-friendliness of their CGM systems, which helped solidify their leadership in the market. Abbott expanded its global footprint by launching its highly popular FreeStyle Libre system in additional international markets, thus broadening its customer base. From 2025 to 2033, these players are expected to continue their focus on innovation, particularly in integrating artificial intelligence to enhance predictive capabilities of CGM devices. Strategic alliances and mergers are anticipated to be prevalent as companies strive to expand their technological capabilities and access new markets. Moreover, as the competition intensifies, companies are likely to invest more in consumer education and direct-to-consumer marketing strategies to increase the adoption rates of their CGM products. The focus on developing less invasive, more accurate, and more integrated CGM solutions will drive the competitive dynamics in this fast-evolving market.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Continuous Glucose Monitoring market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Continuous Glucose Monitoring market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

• Market Segmentation
  • Device/Brand
• Guardian Real Time CGM System
• Dexcom Seven Plus
• Dexcom G4 Platinum
• FreeStyle Navigator
• MiniMed Paradigm Revel/Veo System
• Others
• Region Segment (2023-2033; US$ Million)
• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Continuous Glucose Monitoring market?
• What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Continuous Glucose Monitoring market?
• Which is the largest regional market for Continuous Glucose Monitoring market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Continuous Glucose Monitoring market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Continuous Glucose Monitoring market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Continuous Glucose Monitoring Market
• 2.2. Global Continuous Glucose Monitoring Market, By , 2024 (US$ Million)
• 2.3. Global Continuous Glucose Monitoring Market, By Device/Brand, 2024 (US$ Million)
• 2.4. Global Continuous Glucose Monitoring Market, By Geography, 2024 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2024

3. Continuous Glucose Monitoring Market: Competitive Analysis

• 3.1. Market Positioning of Key Continuous Glucose Monitoring Market Vendors
• 3.2. Strategies Adopted by Continuous Glucose Monitoring Market Vendors
• 3.3. Key Industry Strategies

4. Continuous Glucose Monitoring Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Continuous Glucose Monitoring Market Value, 2023 - 2033, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2024 Versus 2033
• 5.3. Market Segmentation

6. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2024 Versus 2033
• 6.3. Market Segmentation
  • 6.3.1. Guardian Real Time CGM System
  • 6.3.2. Dexcom Seven Plus
  • 6.3.3. Dexcom G4 Platinum
  • 6.3.4. FreeStyle Navigator
  • 6.3.5. MiniMed Paradigm Revel/Veo System
  • 6.3.6. Others

7. North America Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

• 7.1. Market Overview
• 7.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
• 7.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
• 7.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 7.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 7.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 7.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

8. UK and European Union Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

• 8.1. Market Overview
• 8.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
• 8.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
• 8.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.4.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.5.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 8.4.1.6.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

9. Asia Pacific Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

• 9.1. Market Overview
• 9.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
• 9.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
• 9.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.4.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.5.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 9.4.1.6.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

10. Latin America Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

• 10.1. Market Overview
• 10.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
• 10.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
• 10.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 10.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 10.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 10.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

11. Middle East and Africa Continuous Glucose Monitoring Market, 2023-2033, USD (Million)

• 11.1. Market Overview
• 11.2. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
• 11.3. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
• 11.4.Continuous Glucose Monitoring Market: By Region, 2023-2033, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 11.4.1.1.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 11.4.1.2.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. Continuous Glucose Monitoring Market: By , 2023-2033, USD (Million)
      • 11.4.1.3.2. Continuous Glucose Monitoring Market: By Device/Brand, 2023-2033, USD (Million)

12. Company Profile

• 12.1. Abbott
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Bayer AG
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. Dexcom, Inc.
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Glysens Incorporated
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Insulet Corporation
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Medtronic
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Nova Biomedical Corporation
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. Senseonics Incorporated
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Livongo
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. BeatO
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives
• 12.11. Jana Care
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Portfolio
  • 12.11.4. Strategic Initiatives
• 12.12. iXensor
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Portfolio
  • 12.12.4. Strategic Initiatives
• 12.13. DiaMonTech AG.
  • 12.13.1. Company Overview
  • 12.13.2. Financial Performance
  • 12.13.3. Product Portfolio
  • 12.13.4. Strategic Initiatives